2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide

C148H154F11N39O18 — CID 157273039

About 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide

2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide (PubChem CID 157273039) has the molecular formula C148H154F11N39O18 and a molecular weight of 2976.09 g/mol. Its IUPAC name is 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide.

Molecular Properties

• Compound Name: 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide
• PubChem CID: 157273039
• Molecular Formula: C148H154F11N39O18
• Molecular Weight: 2976.09 g/mol
• Exact Mass: 2974.22
• IUPAC Name: 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide
• SMILES: CC(C)(C)c1ccc(-n2cc(NC(=O)c3coc(-c4ccnc(N)c4)n3)c(C(N)=O)n2)cc1.CC(C)(C)c1ccc(-n2cc(NC(=O)c3coc(-c4ccnc(NCC(F)(F)F)c4)n3)c(CCCO)n2)cc1.CC(C)(C)c1ccc(-n2cc(NC(=O)c3coc(-c4ccnc(NCC(F)(F)F)c4)n3)c(N3CCN(CCO)C3=O)n2)cc1.CC(C)(C)c1ccc(-n2cc(NC(=O)c3cocn3)c(C(N)=O)n2)cc1.CC(C)c1ccc(-n2cc(NC(=O)c3coc(-c4cnn(C)c4)n3)c(C(F)F)n2)cc1.CC1(C)CCN(c2nn(-c3ccc(C(C)(C)C)cc3)cc2NC(=O)c2coc(-c3ccnc(NCC(F)(F)F)c3)n2)C1=O
• InChI: InChI=1S/C30H32F3N7O3.C29H31F3N8O4.C27H29F3N6O3.C23H23N7O3.C21H20F2N6O2.C18H19N5O3/c1-28(2,3)19-6-8-20(9-7-19)40-15-21(24(38-40)39-13-11-29(4,5)27(39)42)36-25(41)22-16-43-26(37-22)18-10-12-34-23(14-18)35-17-30(31,32)33;1-28(2,3)19-4-6-20(7-5-19)40-15-21(24(37-40)39-11-10-38(12-13-41)27(39)43)35-25(42)22-16-44-26(36-22)18-8-9-33-23(14-18)34-17-29(30,31)32;1-26(2,3)18-6-8-19(9-7-18)36-14-21(20(35-36)5-4-12-37)33-24(38)22-15-39-25(34-22)17-10-11-31-23(13-17)32-16-27(28,29)30;1-23(2,3)14-4-6-15(7-5-14)30-11-16(19(29-30)20(25)31)27-21(32)17-12-33-22(28-17)13-8-9-26-18(24)10-13;1-12(2)13-4-6-15(7-5-13)29-10-16(18(27-29)19(22)23)25-20(30)17-11-31-21(26-17)14-8-24-28(3)9-14;1-18(2,3)11-4-6-12(7-5-11)23-8-13(15(22-23)16(19)24)21-17(25)14-9-26-10-20-14/h6-10,12,14-16H,11,13,17H2,1-5H3,(H,34,35)(H,36,41);4-9,14-16,41H,10-13,17H2,1-3H3,(H,33,34)(H,35,42);6-11,13-15,37H,4-5,12,16H2,1-3H3,(H,31,32)(H,33,38);4-12H,1-3H3,(H2,24,26)(H2,25,31)(H,27,32);4-12,19H,1-3H3,(H,25,30);4-10H,1-3H3,(H2,19,24)(H,21,25)
• InChIKey: AYTKOQWWALKWFB-UHFFFAOYSA-N
• XLogP: 26.50
• TPSA: 739.69 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 46
• Rotatable Bonds: 40
• Heavy Atoms: 216
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2976.09
LogP ≤ 5	26.50
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	46

Frequently Asked Questions

What is the IUPAC name of 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide?

The IUPAC name of 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide (CID 157273039) is 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide.

What is the SMILES notation for 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide?

The canonical SMILES for 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide is CC(C)(C)c1ccc(-n2cc(NC(=O)c3coc(-c4ccnc(N)c4)n3)c(C(N)=O)n2)cc1.CC(C)(C)c1ccc(-n2cc(NC(=O)c3coc(-c4ccnc(NCC(F)(F)F)c4)n3)c(CCCO)n2)cc1.CC(C)(C)c1ccc(-n2cc(NC(=O)c3coc(-c4ccnc(NCC(F)(F)F)c4)n3)c(N3CCN(CCO)C3=O)n2)cc1.CC(C)(C)c1ccc(-n2cc(NC(=O)c3cocn3)c(C(N)=O)n2)cc1.CC(C)c1ccc(-n2cc(NC(=O)c3coc(-c4cnn(C)c4)n3)c(C(F)F)n2)cc1.CC1(C)CCN(c2nn(-c3ccc(C(C)(C)C)cc3)cc2NC(=O)c2coc(-c3ccnc(NCC(F)(F)F)c3)n2)C1=O.

What is the InChIKey of 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide?

The InChIKey is AYTKOQWWALKWFB-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H32F3N7O3.C29H31F3N8O4.C27H29F3N6O3.C23H23N7O3.C21H20F2N6O2.C18H19N5O3/c1-28(2,3)19-6-8-20(9-7-19)40-15-21(24(38-40)39-13-11-29(4,5)27(39)42)36-25(41)22-16-43-26(37-22)18-10-12-34-23(14-18)35-17-30(31,32)33;1-28(2,3)19-4-6-20(7-5-19)40-15-21(24(37-40)39-11-10-38(12-13-41)27(39)43)35-25(42)22-16-44-26(36-22)18-8-9-33-23(14-18)34-17-29(30,31)32;1-26(2,3)18-6-8-19(9-7-18)36-14-21(20(35-36)5-4-12-37)33-24(38)22-15-39-25(34-22)17-10-11-31-23(13-17)32-16-27(28,29)30;1-23(2,3)14-4-6-15(7-5-14)30-11-16(19(29-30)20(25)31)27-21(32)17-12-33-22(28-17)13-8-9-26-18(24)10-13;1-12(2)13-4-6-15(7-5-13)29-10-16(18(27-29)19(22)23)25-20(30)17-11-31-21(26-17)14-8-24-28(3)9-14;1-18(2,3)11-4-6-12(7-5-11)23-8-13(15(22-23)16(19)24)21-17(25)14-9-26-10-20-14/h6-10,12,14-16H,11,13,17H2,1-5H3,(H,34,35)(H,36,41);4-9,14-16,41H,10-13,17H2,1-3H3,(H,33,34)(H,35,42);6-11,13-15,37H,4-5,12,16H2,1-3H3,(H,31,32)(H,33,38);4-12H,1-3H3,(H2,24,26)(H2,25,31)(H,27,32);4-12,19H,1-3H3,(H,25,30);4-10H,1-3H3,(H2,19,24)(H,21,25).

What are the key properties of 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide?

2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide has a molecular weight of 2976.09 g/mol, XLogP of 26.50, 40 rotatable bonds, 14 hydrogen bond donors, and 46 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(2-amino-4-pyridinyl)-N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-carbamoylpyrazol-4-yl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3,3-dimethyl-2-oxopyrrolidin-1-yl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-[3-(2-hydroxyethyl)-2-oxoimidazolidin-1-yl]pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[1-(4-tert-butylphenyl)-3-(3-hydroxypropyl)pyrazol-4-yl]-2-[2-(2,2,2-trifluoroethylamino)-4-pyridinyl]-1,3-oxazole-4-carboxamide;N-[3-(difluoromethyl)-1-(4-propan-2-ylphenyl)pyrazol-4-yl]-2-(1-methylpyrazol-4-yl)-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 157273039), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).